Nephros, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nephros, Inc. on June 23, 2008, covering events occurring on June 23, 2008, and June 25, 2008. The company is incorporated in Delaware and maintains its principal executive offices in New York, NY.
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document focuses exclusively on corporate governance changes and the notification of an annual meeting.
Material Changes
- Board Composition: The Board of Directors reduced its size from 7 members to 6 members.
- Director Resignation and Re-appointment: Norman J. Barta resigned as a Class III Director and was simultaneously re-appointed as a Class II Director to fill a vacancy. This action was taken to maintain equal class sizes.
- Annual Meeting: The Company held its Annual Meeting of Stockholders on June 25, 2008, where CEO Norman J. Barta and CFO Gerald Kochanski presented an address accompanied by slides.
Guidance, Outlook, and Risks
The filing references slides presented at the Annual Meeting (Exhibit 99.2) containing management commentary. However, the text of this 8-K explicitly states that the information in Item 8.01 and the attached slides is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not subject to the liability of that section. No specific forward-looking guidance, risks, or contingencies are detailed within the body of this report.
Key Facts for Investor Verification
- Verify the current composition of the Board of Directors following the reduction to 6 members.
- Review Exhibit 99.2 (Management Slides) for any strategic updates or financial outlooks presented at the June 25, 2008 Annual Meeting, noting these are not formally filed financial data.
- Confirm the status of Norman J. Barta's role as Class II Director following his resignation from Class III.